4//SEC Filing
Miller Larry Lee 4
Accession 0001104659-23-079131
CIK 0001069899other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:16 PM ET
Size
16.0 KB
Accession
0001104659-23-079131
Insider Transaction Report
Form 4
Miller Larry Lee
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2023-07-05+300,000→ 300,000 total→ Class A Common Stock (300,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.
- [F2]On July 5, 2023, the Compensation Committee approved the grant to the reporting person of 300,000 RSUs subject to performance-based vesting based solely on the Company's stock price.
- [F3]The RSUs will vest on June 30, 2027, in increments of 10% (but no less than 20%) (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of the Company's closing stock price per share for each trading day in the 90 calendar day period ended June 30, 2027 (the "90-Day Average") from $20 to $60 and above, subject to the reporting person's continued employment on such date, and subject to earlier vesting upon certain qualifying termination events. None of the RSUs will vest if the 90-Day Average is below $20, and the maximum vesting percentage for the RSUs is 100% for achievement of a 90-Day Average of $60 or above. Vested shares will be delivered to the reporting person within 30 days after vesting, subject to later delivery in the event of certain trading blackout periods.
Issuer
PHIBRO ANIMAL HEALTH CORP
CIK 0001069899
Entity typeother
Related Parties
1- filerCIK 0001603584
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:16 PM ET
- Size
- 16.0 KB